Since MabSpace Biosciences was founded in 2013, it has participated in 2 rounds of funding. In total MabSpace Biosciences has raised $55.0M. MabSpace Biosciences' last funding round was on May 2018 for a total of $40.0M.
MabSpace Biosciences has 3 investors, including Sequoia Capital China, Lilly Asia Ventures and Lilly Asia Venture. The latest investment occurred in May 2018.
